Begin main content


Last Updated: December 14, 2017
Result type: Reports
Project Number: SR0553-000
Product Line: Common Drug Review

Generic Name: ozenoxacin

Brand Name: Ozanex

Manufacturer: Cipher Pharmaceuticals Inc.

Indications: Impetigo

Manufacturer Requested Reimbursement Criteria7: For the topical treatment of impetigo in patients aged 2 months and older.

Submission Type: New

Project Status: Pending

Call For Patient Input: December 14, 2017

Patient Input Closed: February 9, 2018

Anticipated Date: January 19, 2018

Biosimilar: No

Fee Schedule1: Pending

Submit Feedback


dermatology, pediatrics